Why?
11% of the global population suffers from Irritable Bowel Syndrome (IBS). But the definition and classification of IBS is derived from the Bristol Stool Scale, which relies on patients observing their stool and subjectively classifying it on their own. This leads to inconsistent measurements across patients, making it hard to understand which treatments work for which types of patients. The resulting data from Bristol surveys are also low-resolution and only measure 1 variable of the stool, instead of detailed measurements of multiple characteristics of the stool.
What?
Today we’re releasing Dieta’s proprietary computer vision technology to the world in our free mobile app (iOS, Android). When patients snap a photo of their stool, our AI will immediately classify 5 objective characteristics of the stool:
Consistency: how liquid or solid is the stool?
Fragmentation: how divided is the stool into separate pieces?
Fuzziness: how clear or fuzzy are the edges of the stool?
Volume: how large is the stool?
Bristol Scale: defined above - because this is currently the global standard recognized by gastroenterologists and medical institutions such as the FDA, we’ll be measuring it
Patients can view their resulting data in the Dieta Portal to understand which interventions (diets, medication, supplements) are truly helping them or not. They can also share their data with their doctors or dietitians to help them make better treatment decisions (clinicians: sign up here).